DexCom Inc

DexCom Inc

HQ Country
United States
Profile
Dexcom is the leader in transforming diabetes care and management by providing continuous glucose monitoring (CGM) technology to help patients and healthcare professionals better manage diabetes.
フィルター:
DexCom Inc
Company
Topic
Show
 
2024
28 Oct 2024

Senseonics

Dexcom is a market leader in CGM technology
25 Oct 2024

Insulet

Partnered with Dexcom to provide users access to CGM data from G-series of CGMs, enabling a hybrid closed loop insulin management system.
5 Mar 2024

Welldoc: Diabetes

Partnership first announced in March 2020, integrating BlueStar with Dexcom CGM systems.
19 Jan 2024

Digital Health and Artificial Intelligence 2024-2034: Trends, Opportunities, and Outlook

IDTechEx Report: Dr Tess Skyrme
2023
16 Mar 2023

Dexcom

Dexcom is a US-based biotech company, founded in 1999. The company is one of the market leaders in the continuous glucose monitoring (CGM) industry.
Included are:
3 Mar 2023

Glooko

28 Feb 2023

Diabeloop

2022
12 Sep 2022

Dexcom

Dexcom is a US-based biotech company, founded in 1999 by Scott Glenn, John Burd, Lauren Otsuki, Ellen Preston, and Bret Megargel. The company is one of the market leaders in the continuous glucose monitoring (CGM) industry.
11 May 2022

GlucoRx

Dexcom is a CGM market leader with an established presence in the UK.
2020
8 Jul 2020

Abbott Diabetes Care

Prominent competitor in CGM
2017
27 Jan 2017

GlySens

Manufacturer of continuous glucose monitoring systems. Decom has received FDA approval as a primary medical device, stating that their G5 system is suitable to replace disposable fingerstick testing for diabetics. Currently available in many territories through reimbursement programs.
20 Jan 2017

PKvitality

Manufacture of the first medicare approved continuous glucose monitoring system. The Dexcom G5 has been approved as a replacement for single use finger-stick tests.
2016
28 Nov 2016

DexCom Inc

Technology analyst Dr David Pugh spoke with John Bernard, marketing coordinator at Dexcom about their continuous glucose monitoring systems for diabetes management and the growth of wearables for diabetic patients.
Included are: